yinuotiesiwang.com.cn-少妇久久久久久被弄到高潮,日本护士毛茸茸高潮,一本一本久久A久久精品综合麻豆,波多野结衣网站

產品分類

Products

產品中心/ PRODUCTS

我的位置:首頁  >  產品中心  >    >  動物活體成像設備  >  腫瘤測量儀

腫瘤測量儀

  • 更新時間:2024-10-11
  • 訪  問  量:661

簡要描述:動物腫瘤測量儀,非常適合對大鼠小鼠等動物的皮下腫瘤進行快速測量、分析,精確測量動物腫瘤并對腫瘤信息存檔與跟蹤

在線咨詢

聯系電話:021-54377179

產品詳情

動物腫瘤測量儀,非常適合對大鼠小鼠等動物的皮下腫瘤進行快速測量、分析,精確測量動物腫瘤并對腫瘤信息存檔與跟蹤。


主要技術參數: 

· 測量范圍:0-25mm腫瘤尺寸:20*20*20mm
· 3D測量精確度:<0.3mm
· 圖像捕捉時間:0.1s
· 接口:USB 2.0
· 相機:1600*1200 像素(2MP)
· 工作距離:50mm


動物腫瘤測量分析儀的主要特點: 
· 手持式成像裝置,實現立體成像;
· 適合測量不同尺寸的腫瘤;
· 方便使用:觸屏式電腦,操作方便;
· 內置軟件,自動計算腫瘤尺寸,跟蹤整個實驗進展。 
  

· 快速,高效,保證了高通量和可靠測量;
· 全自動測量跟蹤系統;
· 實時數據分析與處理。 


     
  
 


部分用戶: 

Hunter College, CUNY

Vanderbilt University Medical Center

Hainan Medical University

Howard Hughes Medical Institute

Memorial Sloan Kettering Cancer Center

Cancer Center Amsterdam

GlaxoSmithKline

Imec

K.U.Leuven

Neuro-Electronics Research Flanders

Pepric

PharmaVize

reMYND

University Ghent

SEPS Pharma

Vlaams Instituut voor Biotechnologie

University Antwerp

ThromboGenics

Janssen Pharmaceutica

City University of Hong Kong


參考文獻:

1.Adams EJ, Karthaus WR, Hoover E, et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature. 2019;571(7765):408-412. doi:10.1038/s41586-019-1318-9.
2.Zhang Z, Zhou C, Li X, et al. Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation. Cancer Cell. 2020;37(4):584-598.e11. doi:10.1016/j.ccell.2020.03.001.
3.Santich BH, Park JA, Tran H, et al. Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies. Sci Transl Med. 2020;12(534):eaax1315. doi:10.1126/scitranslmed.aax1315.
4.Park JA, Xu H, Cheung, I, et al. Abstract B38: Tetravalent bispecific antibodies specific for HER2 and disialoganglioside GD2 to engage polyclonal T cells for osteosarcoma therapy. Cancer Res. 2018;78(19),B38.doi:10.1158/1538-7445.PEDCA17-B38.
5.Wu CF, Wu CY, Lin CF, et al. The anticancer effects of cyanidin 3-O-glucoside combined with 5-fluorouracil on lung large-cell carcinoma in nude mice. Biomed Pharmacother. 2022;151:113128. doi:10.1016/j.biopha.2022.113128.
6.Wang L, Hoseini SS, Xu H, et al. Silencing Fc Domains in T cell-Engaging Bispecific Antibodies Improves T-cell Trafficking and Antitumor Potency. Cancer Immunol Res. 2019;7(12):2013-2024. doi:10.1158/2326-6066.CIR-19-0121.
7.Grochowska A, Statkiewicz M, Kulecka M, et al. Evidence supporting the oncogenic role of BAZ1B in colorectal cancer. Am J Cancer Res. 2022;12(10):4751-4763. 
8.Hoseini SS, Vadlamudi M, Espinosa-Cotton M, et al. T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia. J Immunother Cancer. 2021;9(5):e002509. doi:10.1136/jitc-2021-002509.
9.Beguin E, Gray MD, Logan KA, et al. Magnetic microbubble mediated chemo-sonodynamic therapy using a combined magnetic-acoustic device. J Control Release. 2020;317:23-33. doi:10.1016/j.jconrel.2019.11.013.
10.Mao N, Gao D, Hu W, et al. Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes. Mol Cancer Ther. 2019;18(9):1577-1586. doi:10.1158/1535-7163.MCT-18-1386.
11.Wu Z, Guo HF, Xu H, et al. Development of a Tetravalent Anti-GPA33/Anti-CD3 Bispecific Antibody for Colorectal Cancers. Mol Cancer Ther. 2018;17(10):2164-2175. doi:10.1158/1535-7163.MCT-18-0026.
12.Poty S, Mandleywala K, O'Neill E, et al. 89Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma. Theranostics. 2020;10(13):5802-5814. doi:10.7150/thno.44772.
13.Hoseini SS, Guo H, Wu Z, et al. A potent tetravalent T-cell-engaging bispecific antibody against CD33 in acute myeloid leukemia. Blood Adv. 2018;2(11):1250-1258. doi:10.1182/bloodadvances.2017014373.
14.Zhang Z, Karthaus WR, Lee YS, et al. Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer. Cancer Cell. 2020;38(2):279-296.e9. doi:10.1016/j.ccell.2020.06.005.
15.Poty S, Carter LM, Mandleywala K, et al. Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2019;25(2):868-880. doi:10.1158/1078-0432.CCR-18-1650.




    

    

    :,

         

    :

    yuyanbio

    :yuyanbio

    

在線咨詢

留言框

  • 產品:

  • 您的單位:

  • 您的姓名:

  • 聯系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結果(填寫阿拉伯數字),如:三加四=7
上海玉研科學儀器有限公司
地址:上海市閔行區興梅路485號眾欣大廈506室
郵箱:sales@yuyanbio.com
傳真:021-35183767
掃一掃關注我們
SCAN